Advertisement

Reactions Weekly

, Volume 1734, Issue 1, pp 293–293 | Cite as

Ipilimumab/nivolumab

Hypophysitis with panhypopituitarism, central diabetes insipidus and type 1 diabetes mellitus: case report
Case report
  • 17 Downloads

Reference

  1. Gunawan F, et al. Combination immune checkpoint inhibitor therapy nivolumab and ipilimumab associated with multiple endocrinopathies. Endocrinology, Diabetes and Metabolism Case Reports 2018: 17-0146, No. 1, Jan 2018. Available from: URL: http://doi.org/10.1530/EDM17-0146 - Australia

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations